# RHA® 3 Versus Restylane-L® for Lip Augmentation

> **NCT04540913** · — · COMPLETED · sponsor: **Teoxane SA** · enrollment: 202 (actual)

## Conditions studied

- Lip Augmentation
- Lip

## Interventions

- **DEVICE:** RHA 3
- **DEVICE:** Restylane-L

## Key facts

- **NCT ID:** NCT04540913
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-22
- **Primary completion:** 2022-05-11
- **Final completion:** 2022-09-07
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04540913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04540913, "RHA® 3 Versus Restylane-L® for Lip Augmentation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04540913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*